ArticleJAMA network open2024
Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases.
Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Emerging risks of health optimisation: refractory nausea associated with peptide injections reported to contain retatrutide.BMJ case reports · 2026Article
- Tirzepatide and Glucagon-like Peptide-1/Glucose-dependent Insulinotropic Polypeptide Therapy: Quality of Life, Filipino Diet Culture, and Safe Access.JMA journal · 2026Article
- Real-world experiences with obesity medication in the Netherlands: A mixed methods study among patients and professionals.Obesity pillars · 2026Article
- A Cross-Sectional Survey of Sport Physicians' Perceptions of Glucagon-Like Peptide-1 Drug Use in Sport.Sports medicine (Auckland, N.Z.) · 2026Article
- GLP-1 guidelines amid an obesity epidemic: a poor fit for the Global South.Archives of public health = Archives belges de sante publique · 2026Article
- Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study.Health affairs scholar · 2026Article
- Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity.BMJ open diabetes research & care · 2026Review
- Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance.Frontiers in pharmacology · 2026Article
- Assessing the quality and reliability of health information on GLP-1 receptor agonists on TikTok and Bilibili: a cross-sectional analysis of the public health infodemic.Therapeutic advances in endocrinology and metabolism · 2026Article
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026.Diabetes care · 2026Review
- Euglycemic Ketoacidosis Following the Use of Counterfeit Semaglutide for Weight Loss.Cureus · 2026 · on this mapArticle
- GLP-1 Receptor Agonist-Associated Weight Loss and Aesthetic Breast Surgery: A Narrative Review and Experience-Based Recommendations for Plastic and Reconstructive Surgeons.Aesthetic surgery journal. Open forum · 2026Article
- Global Rise of Compounded Weight-Loss Medicines: A Worrisome Trend.Journal of the Endocrine Society · 2025Article
- Bariatric and metabolic surgery medical tourism: the compelling need for regulation through transnational collaboration.BMJ global health · 2025Article
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025.Diabetes care · 2025 · on this mapReview
- Navigating Cost and Access Barriers for Medications in the Treatment of Obesity: A Guide for Patients and Primary Care Clinicians.Clinical diabetes : a publication of the American Diabetes Association · 2025Review
- A qualitative exploration of consumers' views and experiences toward online pharmacies: Narrative from a developing country.PloS one · 2025Article
- A comparison of Glucagon-like peptide-1 receptor agonists on weight change, side effects, and quality of life in Kuwait.Frontiers in nutrition · 2025Article
- Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.Journal of medical Internet research · 2024Article
- Editorial: Internet pharmacies and the online pharmacy market: trends, perspectives and challenges.Frontiers in pharmacology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.